Governance

The Group’s governance bodies

For more than 70 years, the Group has been led by men and women with a passion for innovation and a shared vision. It is governed by an Executive Committee (EXCOM) and a Supervisory Board.

 

To deal with complex problems and gain agility, it is necessary to be able to draw on the knowledge and experience of all. Since 2019, the Group has embarked on a managerial transformation that enables it to take advantage of collective intelligence. A less hierarchical model where expertise gives way to co-construction, where we dare to trust and which integrates the emotional dimension as part of working relationships and decision-making.

 

The shareholders

The Group is a family business that is 100% privately owned.

Granddaughter of René and Simone MOULIN, who created the Biocanina brand, and daughter of Jean MOULIN, who developed the Group in the 80s and 90s with Chantal LUGNIER, Anne MOULIN is now the Group’s main shareholder.

At the origin of the Group’s international ambitions, she decided in 2022 to move to the United States to create and develop the Dômes Pharma US subsidiary.

Anne MOULIN

Principal sharehold, president of Dômes Pharma US

The ExCom (Executive Committee)

The ExCOM is responsible for the management of the Dômes Pharma holding company and its subsidiaries. It is the operational management body. This collegial governance corresponds to a mode of operation which, for decision-making, favours consultation and exchange.

Sébastien BOUSSEMART

Dr. Veterinarian – Business Development – COO

Etienne SAUNIER

Dr. Veterinarian – R&D Director

Eric MARMONIER

Financial Director

Aline ALEDO

Human Resources Director

Christophe MANTION

Industrial Director

Philippe ROYNARD

France Business Director

Paul THIOU

International Business Director

Dominique MOULIN

Dr. of Pharmacy – Head of Directoire

The Supervisory Board

The Supervisory Board of the Dômes Pharma Group is composed of 2/3 shareholders and 1/3 external experts. Its mission is to ensure the proper functioning of the group’s companies and to report to the shareholders. It meets at least four times a year. It is chaired by Jean Moulin, son of René and Simone Moulin, founders of the group’s first company and co-founder with Chantal Lugnier, of the holding company DÔMES PHARMA.

Jean MOULIN

President – Doctor of Pharmacy

Chantal LUGNIER

Member – Doctor of Pharmacy

Isabelle MOULIN

Member – Doctor of Pharmacy

Our History

Our History

It took boldness to build a group capable of existing alongside the big players in the pharmaceutical industry.

read more

Our Subsidiaries

Our Subsidiaries

The Dômes Pharma group consists of a parent company and 7 subsidiaries in France and around the world.

read more